These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4005108)

  • 1. Posture and theophylline kinetics.
    Warren JB; Cuss F; Barnes PJ
    Br J Clin Pharmacol; 1985 May; 19(5):707-9. PubMed ID: 4005108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posture and circadian variations in serum theophylline concentrations].
    Kishida M; Hukushima K; Iikura Y
    Arerugi; 1990 Oct; 39(10):1422-6. PubMed ID: 2260930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of posture on the sympathoadrenal response to theophylline infusion.
    Warren JB; Turner C; Dalton N; Thomson A; Cochrane GM; Clark TJ
    Br J Clin Pharmacol; 1983 Oct; 16(4):405-11. PubMed ID: 6313028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a sustained-release theophylline formulation.
    Trembath PW; Boobois SW
    Br J Clin Pharmacol; 1980 Apr; 9(4):365-9. PubMed ID: 7378252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of pharmacokinetics after halving a slow-release theophylline tablet.
    Primrose WR; Clee MD; Moody JP; Hockings N
    Pharmatherapeutica; 1983; 3(6):429-32. PubMed ID: 6622502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of food on the absorption of sustained-release theophylline and comparison of two methods for serum theophylline analysis.
    Boner AL; Bennati D; Valletta EA; Plebani M; Stevens MT; Scott JC
    J Clin Pharmacol; 1986; 26(8):638-42. PubMed ID: 3793957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a sustained-release theophylline preparation in healthy subjects.
    Goto M; Nakamoto Y; Sugiyama M; Yamashina H
    J Pharmacobiodyn; 1983 Apr; 6(4):225-31. PubMed ID: 6620110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New method for bioavailability assessment of slow-release preparations of theophylline.
    Kasuya Y; Ohno T; Kubota N; Takahashi H; Hirayama H
    J Pharmacokinet Biopharm; 1985 Dec; 13(6):571-87. PubMed ID: 3834072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
    Bialer M; Salame K; Raz I
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers.
    Talseth T; Boye NP; Bredesen JE; Kornstad S
    Ann Allergy; 1981 May; 46(5):279-80. PubMed ID: 7235323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.
    Hibberd SG; Alveyn C; Coombes EJ; Holgate ST
    Br J Clin Pharmacol; 1986 Sep; 22(3):337-41. PubMed ID: 3768245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal variations in trough serum theophylline concentrations at steady state.
    Lesko LJ; Brousseau D; Canada AT; Eastwood G
    J Pharm Sci; 1980 Mar; 69(3):358-9. PubMed ID: 7381723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline.
    Goldberg MJ; Spector R; Park GD; Johnson GF; Roberts P
    Clin Pharmacol Ther; 1987 Jan; 41(1):108-11. PubMed ID: 3802699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.